Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients

Risk stratification in acute myeloid leukemia (AML) patients using prognostic parameters at diagnosis is effective, but may be significantly improved by the use of on treatment parameters which better define the actual sensitivity to therapy in the single patient. Minimal residual disease (MRD) moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagola, Michele, Skert, Cristina, Borlenghi, Erika, Chiarini, Marco, Cattaneo, Chiara, Morello, Enrico, Cancelli, Valeria, Cattina, Federica, Cerqui, Elisa, Pagani, Chiara, Passi, Angela, Ribolla, Rossella, Bernardi, Simona, Giustini, Viviana, Lamorgese, Cinzia, Ruggeri, Giuseppina, Imberti, Luisa, Caimi, Luigi, Russo, Domenico, Rossi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735778/
https://www.ncbi.nlm.nih.gov/pubmed/26715369
http://dx.doi.org/10.1002/cam4.593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735778/
https://www.ncbi.nlm.nih.gov/pubmed/26715369
http://dx.doi.org/10.1002/cam4.593

Ejemplares similares